首页 > 最新文献

Osong Public Health and Research Perspectives最新文献

英文 中文
Number of comorbidities and the risk of delay in seeking treatment for coronary heart disease: a longitudinal study in Bogor City, Indonesia. 合并症数量与冠心病就诊延迟风险:印度尼西亚茂物市的一项纵向研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2023.0337
Sulistyowati Tuminah, Lely Indrawati, Woro Riyadina, Tri Wurisastuti, Alfons M Letelay, Nikson Sitorus, Alifa S Putri, Siti Isfandari, Irmansyah Irmansyah

Background: The aim of this study was to investigate the relationship between the number of patient comorbidities and the delays in seeking treatment for coronary heart disease (CHD).

Methods: This longitudinal study utilized secondary data from the Non-Communicable Disease Risk Factor (NCDRF) cohort study conducted in Bogor City. Individuals who participated in the NCDRF cohort study and were diagnosed with CHD within the 6-year study period met the inclusion criteria. Respondents who were not continuously monitored up to the 6th year were excluded. The final sample included data from respondents with CHD who participated in the NCDRF cohort study and were monitored for the full 6-year duration. The final logistic regression analysis was conducted on data collected from 812 participants.

Results: Among the participants with CHD, 702 out of 812 exhibited a delay in seeking treatment. The risk of a delay in seeking treatment was significantly higher among individuals without comorbidities, with an odds ratio (OR) of 3.5 (95% confidence interval [CI], 1.735-7.036; p<0.001). Among those with a single comorbidity, the risk of delay in seeking treatment was still notable (OR, 2.6; 95% CI, 1.259-5.418; p=0.010) when compared to those with 2 or more comorbidities. These odds were adjusted for age, sex, education level, and health insurance status.

Conclusion: The proportion of patients with CHD who delayed seeking treatment was high, particularly among individuals with no comorbidities. Low levels of comorbidity also appeared to correlate with a greater tendency to delay in seeking treatment.

研究背景本研究旨在调查患者合并症数量与冠心病(CHD)就诊延迟之间的关系:这项纵向研究利用了在茂物市进行的非传染性疾病风险因素(NCDRF)队列研究的二手数据。参与 NCDRF 队列研究并在 6 年研究期内被诊断出患有冠心病的人符合纳入标准。未持续监测至第 6 年的受访者被排除在外。最终样本包括参与 NCDRF 队列研究并在整个 6 年研究期间接受监测的患有冠心病的受访者的数据。最终的逻辑回归分析是针对 812 名参与者的数据进行的:结果:在 812 名患有慢性阻塞性肺病的参与者中,有 702 人表现出延迟就医的情况。没有合并症的患者延迟就医的风险明显更高,赔率比(OR)为 3.5(95% 置信区间 [CI],1.735-7.036;p):延迟就医的心脏病患者比例很高,尤其是在无合并症的患者中。合并症水平低似乎也与更倾向于延迟就医有关。
{"title":"Number of comorbidities and the risk of delay in seeking treatment for coronary heart disease: a longitudinal study in Bogor City, Indonesia.","authors":"Sulistyowati Tuminah, Lely Indrawati, Woro Riyadina, Tri Wurisastuti, Alfons M Letelay, Nikson Sitorus, Alifa S Putri, Siti Isfandari, Irmansyah Irmansyah","doi":"10.24171/j.phrp.2023.0337","DOIUrl":"10.24171/j.phrp.2023.0337","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study was to investigate the relationship between the number of patient comorbidities and the delays in seeking treatment for coronary heart disease (CHD).</p><p><strong>Methods: </strong>This longitudinal study utilized secondary data from the Non-Communicable Disease Risk Factor (NCDRF) cohort study conducted in Bogor City. Individuals who participated in the NCDRF cohort study and were diagnosed with CHD within the 6-year study period met the inclusion criteria. Respondents who were not continuously monitored up to the 6th year were excluded. The final sample included data from respondents with CHD who participated in the NCDRF cohort study and were monitored for the full 6-year duration. The final logistic regression analysis was conducted on data collected from 812 participants.</p><p><strong>Results: </strong>Among the participants with CHD, 702 out of 812 exhibited a delay in seeking treatment. The risk of a delay in seeking treatment was significantly higher among individuals without comorbidities, with an odds ratio (OR) of 3.5 (95% confidence interval [CI], 1.735-7.036; p<0.001). Among those with a single comorbidity, the risk of delay in seeking treatment was still notable (OR, 2.6; 95% CI, 1.259-5.418; p=0.010) when compared to those with 2 or more comorbidities. These odds were adjusted for age, sex, education level, and health insurance status.</p><p><strong>Conclusion: </strong>The proportion of patients with CHD who delayed seeking treatment was high, particularly among individuals with no comorbidities. Low levels of comorbidity also appeared to correlate with a greater tendency to delay in seeking treatment.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 3","pages":"201-211"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization. 加强卫生系统,包括以创新方式调动预算,是扩大免疫计划面临的一个紧迫问题。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2024.0181
Jong-Koo Lee
{"title":"Strengthening the health system, including innovative budget mobilization, is an urgent issue for the Expanded Programme on Immunization.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2024.0181","DOIUrl":"10.24171/j.phrp.2024.0181","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 3","pages":"187-188"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237321/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Mycobacterium bovis outbreak among exhibition animals at a zoo in the Republic of Korea: the first contact investigation of zoonotic tuberculosis. 大韩民国动物园展出动物中爆发的牛分枝杆菌病:人畜共患结核病的首次接触调查。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.24171/j.phrp.2023.0228
Hye Young Lee, Yunhyung Kwon, Sang-Eun Lee, Jieun Kim, Hoyong Choi

Background: Between July 2, 2021, and September 20, 2022, a Mycobacterium bovis outbreak occurred among exhibition animals at a zoo in the Republic of Korea. This study was conducted to assess the likelihood of M. bovis transmission to human contacts through a contact investigation and to implement preventive treatment for latent tuberculosis infection (LTBI).

Methods: In this descriptive study, the Korea Disease Control and Prevention Agency conducted a contact investigation, which included interviews, interferon-gamma release assay (IGRA) tests, and chest X-rays. Contacts underwent IGRA testing on 2 occasions: initial testing of 29 contacts (15 in the first cluster of infection and 14 in the second cluster) and follow-up testing of the 15 contacts in the first cluster.

Results: The study included 29 participants, 18 of whom were male (62.1%) and 11 female (37.9%). The mean participant age was 37.3 years (standard deviation, 9.6 years). In the initial IGRA tests, 6 of the 29 participants tested positive, indicating a prevalence of 20.7%. Following prolonged exposure, 1 additional positive case was detected in follow-up testing, raising the prevalence of LTBI to 24.1%. None of the contacts had active tuberculosis. Among the 7 individuals with positive results, 2 (28.6%) underwent treatment for LTBI.

Conclusion: This study faced challenges in confirming the transmission of M. bovis infection from infected animals to humans in the Republic of Korea. Nevertheless, adopting a One Health approach necessitates the implementation of surveillance systems and infection control protocols, particularly for occupational groups at high risk of exposure.

背景:2021年7月2日至2022年9月20日期间,大韩民国一家动物园的展览动物中爆发了牛分枝杆菌疫情。本研究旨在通过接触调查评估牛分枝杆菌传播给人类接触者的可能性,并对潜伏肺结核感染(LTBI)实施预防性治疗:在这项描述性研究中,韩国疾病预防控制机构进行了接触者调查,包括访谈、干扰素-γ释放测定(IGRA)检测和胸部 X 光检查。接触者接受了两次 IGRA 检测:对 29 名接触者(第一组感染者中的 15 人和第二组感染者中的 14 人)进行了初次检测,并对第一组感染者中的 15 名接触者进行了后续检测:研究包括 29 名参与者,其中 18 名男性(62.1%),11 名女性(37.9%)。参与者的平均年龄为 37.3 岁(标准差为 9.6 岁)。在最初的 IGRA 检测中,29 名参与者中有 6 人检测呈阳性,患病率为 20.7%。随着接触时间的延长,在后续检测中又发现了 1 例阳性病例,使 LTBI 患病率上升至 24.1%。接触者中没有人患有活动性肺结核。在结果呈阳性的 7 人中,有 2 人(28.6%)接受了治疗:本研究在确认大韩民国受感染动物向人类传播牛海绵状芽孢杆菌感染方面面临挑战。尽管如此,要采取 "一体健康 "方法,就必须实施监测系统和感染控制方案,尤其是针对高危职业人群。
{"title":"A Mycobacterium bovis outbreak among exhibition animals at a zoo in the Republic of Korea: the first contact investigation of zoonotic tuberculosis.","authors":"Hye Young Lee, Yunhyung Kwon, Sang-Eun Lee, Jieun Kim, Hoyong Choi","doi":"10.24171/j.phrp.2023.0228","DOIUrl":"10.24171/j.phrp.2023.0228","url":null,"abstract":"<p><strong>Background: </strong>Between July 2, 2021, and September 20, 2022, a Mycobacterium bovis outbreak occurred among exhibition animals at a zoo in the Republic of Korea. This study was conducted to assess the likelihood of M. bovis transmission to human contacts through a contact investigation and to implement preventive treatment for latent tuberculosis infection (LTBI).</p><p><strong>Methods: </strong>In this descriptive study, the Korea Disease Control and Prevention Agency conducted a contact investigation, which included interviews, interferon-gamma release assay (IGRA) tests, and chest X-rays. Contacts underwent IGRA testing on 2 occasions: initial testing of 29 contacts (15 in the first cluster of infection and 14 in the second cluster) and follow-up testing of the 15 contacts in the first cluster.</p><p><strong>Results: </strong>The study included 29 participants, 18 of whom were male (62.1%) and 11 female (37.9%). The mean participant age was 37.3 years (standard deviation, 9.6 years). In the initial IGRA tests, 6 of the 29 participants tested positive, indicating a prevalence of 20.7%. Following prolonged exposure, 1 additional positive case was detected in follow-up testing, raising the prevalence of LTBI to 24.1%. None of the contacts had active tuberculosis. Among the 7 individuals with positive results, 2 (28.6%) underwent treatment for LTBI.</p><p><strong>Conclusion: </strong>This study faced challenges in confirming the transmission of M. bovis infection from infected animals to humans in the Republic of Korea. Nevertheless, adopting a One Health approach necessitates the implementation of surveillance systems and infection control protocols, particularly for occupational groups at high risk of exposure.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 3","pages":"248-259"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237313/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Periodontitis and non-communicable diseases in a Brazilian population, a cross-sectional study, Vila Velha-ES, Brazil. 巴西人口牙周炎与非传染性疾病的横断面研究,巴西 Vila Velha-ES。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-06-27 DOI: 10.24171/j.phrp.2024.0021
Gustavo Vital de Mendonça, Crispim Cerutti Junior, Alfredo Carlos Rodrigues Feitosa, Brígida Franco Sampaio de Mendonça, Lucia Helena Sagrillo Pimassoni

Background: The objective of this study was to examine the hypothesis that periodontal disease is associated with chronic non-communicable diseases.

Methods: In this cross-sectional study, we evaluated the periodontal health condition of the population, based on the community periodontal index, as well as the number of missing teeth and the presence of systemic health conditions. We quantified the association between oral health and the presence of chronic diseases using simple logistic regression, adjusting for confounding factors including age, smoking, and overweight.

Results: The study population consisted of 334 volunteers, aged between 19 and 81 years. In patients over 45 years old, periodontal disease was found to be significantly associated with hypertension and diabetes. Furthermore, in female patients, periodontal disease was significantly associated with hypertension, diabetes, and cancer.

Conclusion: Our findings indicate that periodontal disease is positively and significantly associated with both arterial hypertension and diabetes, independent of potential confounding factors.

背景:本研究旨在探讨牙周病与慢性非传染性疾病相关的假设:本研究旨在探讨牙周病与慢性非传染性疾病相关的假设:在这项横断面研究中,我们根据社区牙周指数评估了人口的牙周健康状况,以及缺牙数量和是否存在全身性健康问题。我们使用简单的逻辑回归方法量化了口腔健康与慢性疾病之间的关系,并对年龄、吸烟和超重等混杂因素进行了调整:研究对象包括 334 名志愿者,年龄在 19 岁至 81 岁之间。在 45 岁以上的患者中,牙周病与高血压和糖尿病有显著相关性。此外,在女性患者中,牙周病与高血压、糖尿病和癌症有明显关联:我们的研究结果表明,牙周病与动脉高血压和糖尿病均有显著的正相关关系,不受潜在混杂因素的影响。
{"title":"Periodontitis and non-communicable diseases in a Brazilian population, a cross-sectional study, Vila Velha-ES, Brazil.","authors":"Gustavo Vital de Mendonça, Crispim Cerutti Junior, Alfredo Carlos Rodrigues Feitosa, Brígida Franco Sampaio de Mendonça, Lucia Helena Sagrillo Pimassoni","doi":"10.24171/j.phrp.2024.0021","DOIUrl":"10.24171/j.phrp.2024.0021","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to examine the hypothesis that periodontal disease is associated with chronic non-communicable diseases.</p><p><strong>Methods: </strong>In this cross-sectional study, we evaluated the periodontal health condition of the population, based on the community periodontal index, as well as the number of missing teeth and the presence of systemic health conditions. We quantified the association between oral health and the presence of chronic diseases using simple logistic regression, adjusting for confounding factors including age, smoking, and overweight.</p><p><strong>Results: </strong>The study population consisted of 334 volunteers, aged between 19 and 81 years. In patients over 45 years old, periodontal disease was found to be significantly associated with hypertension and diabetes. Furthermore, in female patients, periodontal disease was significantly associated with hypertension, diabetes, and cancer.</p><p><strong>Conclusion: </strong>Our findings indicate that periodontal disease is positively and significantly associated with both arterial hypertension and diabetes, independent of potential confounding factors.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 3","pages":"212-220"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study. 印度德里 COVID-19 后症状康复者的患病率和模式:一项基于人群的研究。
IF 2.1 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.24171/j.phrp.2023.0251
Nidhi Bhatnagar, Mongjam Meghachandra Singh, Hitakshi Sharma, Suruchi Mishra, Gurmeet Singh, Shivani Rao, Amod Borle, Tanu Anand, Naresh Kumar, Binita Goswami, Sarika Singh, Mahima Kapoor, Sumeet Singla, Bembem Khuraijam, Nita Khurana, Urvi Sharma, Suneela Garg

Background: Post-coronavirus disease 2019 (COVID-19) symptoms were widely reported. However, data on post-COVID-19 conditions following infection with the Omicron variant remained scarce. This prospective study was conducted to understand the prevalence, patterns, and duration of symptoms in patients who had recovered from COVID-19.

Methods: A prospective study was conducted across 11 districts of Delhi, India, among individuals who had recovered from COVID-19. Study participants were enrolled, and then returned for post-recovery follow-up at 3 months and 6 months interval.

Results: The mean age of study participants was 42.07 years, with a standard deviation of 14.89 years. The majority of the participants (79.7%) reported experiencing post-COVID-19 symptoms. The most common symptoms included joint pain (36.0%), persistent dry cough (35.7%), anxiety (28.4%), and shortness of breath (27.1%). Other symptoms were persistent fatigue (21.6%), persistent headache (20.0%), forgetfulness (19.7%), and limb weakness (18.6%). The longest duration of symptom was observed to be anxiety (138.75±54.14 days), followed by fatigue (137.57±48.33 days), shortness of breath (131.89±60.21 days), and joint pain/swelling (131.59±58.76 days). At the first follow-up visit, 2.2% of participants presented with abnormal electrocardiogram readings, but no abnormalities were noticed during the second follow-up. Additionally, 4.06% of participants exhibited abnormal chest X-ray findings at the first followup, which decreased to 2.16% by the second visit.

Conclusion: The most frequently reported post-COVID-19 symptoms were joint pain, dry cough, anxiety and shortness of breath. These clinical symptoms persisted for up to 6 months, with evidence of multi-system involvement. Consequently, findings highlighted the need for long-term follow-up during the post-COVID-19 period.

背景:科罗纳病毒病 2019(COVID-19)后症状被广泛报道。然而,有关感染奥米克隆变种后 COVID-19 后症状的数据仍然很少。本前瞻性研究旨在了解 COVID-19 康复患者症状的发生率、模式和持续时间:在印度德里的 11 个区对 COVID-19 康复者进行了前瞻性研究。研究人员注册后,分别在 3 个月和 6 个月后进行康复后随访:研究参与者的平均年龄为 42.07 岁,标准差为 14.89 岁。大多数参与者(79.7%)表示出现了 COVID-19 后症状。最常见的症状包括关节疼痛(36.0%)、持续干咳(35.7%)、焦虑(28.4%)和呼吸急促(27.1%)。其他症状包括持续疲劳(21.6%)、持续头痛(20.0%)、健忘(19.7%)和四肢无力(18.6%)。症状持续时间最长的是焦虑(138.75±54.14 天),其次是疲劳(137.57±48.33 天)、气短(131.89±60.21 天)和关节疼痛/肿胀(131.59±58.76 天)。在第一次随访时,2.2%的参与者出现心电图读数异常,但在第二次随访时未发现异常。此外,4.06%的参与者在首次随访时发现胸部X光检查结果异常,第二次随访时这一比例降至2.16%:结论:COVID-19 后最常见的症状是关节疼痛、干咳、焦虑和气短。这些临床症状持续时间长达 6 个月,有证据表明涉及多个系统。因此,研究结果凸显了在 COVID-19 后期间进行长期随访的必要性。
{"title":"Prevalence and patterns of post-COVID-19 symptoms in recovered patients of Delhi, India: a population-based study.","authors":"Nidhi Bhatnagar, Mongjam Meghachandra Singh, Hitakshi Sharma, Suruchi Mishra, Gurmeet Singh, Shivani Rao, Amod Borle, Tanu Anand, Naresh Kumar, Binita Goswami, Sarika Singh, Mahima Kapoor, Sumeet Singla, Bembem Khuraijam, Nita Khurana, Urvi Sharma, Suneela Garg","doi":"10.24171/j.phrp.2023.0251","DOIUrl":"10.24171/j.phrp.2023.0251","url":null,"abstract":"<p><strong>Background: </strong>Post-coronavirus disease 2019 (COVID-19) symptoms were widely reported. However, data on post-COVID-19 conditions following infection with the Omicron variant remained scarce. This prospective study was conducted to understand the prevalence, patterns, and duration of symptoms in patients who had recovered from COVID-19.</p><p><strong>Methods: </strong>A prospective study was conducted across 11 districts of Delhi, India, among individuals who had recovered from COVID-19. Study participants were enrolled, and then returned for post-recovery follow-up at 3 months and 6 months interval.</p><p><strong>Results: </strong>The mean age of study participants was 42.07 years, with a standard deviation of 14.89 years. The majority of the participants (79.7%) reported experiencing post-COVID-19 symptoms. The most common symptoms included joint pain (36.0%), persistent dry cough (35.7%), anxiety (28.4%), and shortness of breath (27.1%). Other symptoms were persistent fatigue (21.6%), persistent headache (20.0%), forgetfulness (19.7%), and limb weakness (18.6%). The longest duration of symptom was observed to be anxiety (138.75±54.14 days), followed by fatigue (137.57±48.33 days), shortness of breath (131.89±60.21 days), and joint pain/swelling (131.59±58.76 days). At the first follow-up visit, 2.2% of participants presented with abnormal electrocardiogram readings, but no abnormalities were noticed during the second follow-up. Additionally, 4.06% of participants exhibited abnormal chest X-ray findings at the first followup, which decreased to 2.16% by the second visit.</p><p><strong>Conclusion: </strong>The most frequently reported post-COVID-19 symptoms were joint pain, dry cough, anxiety and shortness of breath. These clinical symptoms persisted for up to 6 months, with evidence of multi-system involvement. Consequently, findings highlighted the need for long-term follow-up during the post-COVID-19 period.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 3","pages":"229-237"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11237315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review. 与大韩民国批准的 COVID-19 疫苗相关的精神不良事件:系统综述。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-01 Epub Date: 2024-03-28 DOI: 10.24171/j.phrp.2023.0325
Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, Byung-Joo Park, Sanghoon Oh

This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023. Risk of bias was assessed using the Risk of Bias Assessment Tool for Non-randomized Studies 2.0. The study protocol was registered in the International Prospective Register of Systematic Reviews (CRD42023449422). Of the 301 articles initially selected, 7 were included in the final analysis. All studies reported on sleep disturbances, and 2 highlighted anxiety-related AEs. Sleep disorders like insomnia and narcolepsy were the most prevalent AEs, while depression was not reported. Our review suggests that these AEs may have been influenced by biological mechanisms as well as the broader psychosocial context of the COVID-19 pandemic. Although this study had limitations, such as a primary focus on the BNT162b2 vaccine and an observational study design, it offered a systematic, multi-vaccine analysis that fills a critical gap in the existing literature. This review underscores the need for continued surveillance of psychiatric AEs and guides future research to investigate underlying mechanisms, identify risk factors, and inform clinical management.

本系统综述评估了接种2019年冠状病毒病(COVID-19)疫苗后的精神不良事件(AEs)。我们纳入了报告或调查在大韩民国接种了经批准的 COVID-19 疫苗的人发生精神科不良事件的研究。我们于2023年3月22日对Ovid-Medline、Embase、CENTRAL和KoreaMed数据库进行了系统的电子检索。使用非随机研究偏倚风险评估工具 2.0 对偏倚风险进行了评估。研究方案已在《国际系统综述前瞻性注册》(CRD42023449422)中注册。在初步筛选出的 301 篇文章中,有 7 篇被纳入最终分析。所有研究都报告了睡眠障碍,其中 2 项研究强调了与焦虑相关的 AE。失眠和嗜睡症等睡眠障碍是最常见的不良反应,而抑郁症则未见报道。我们的综述表明,这些 AEs 可能受到生物机制以及 COVID-19 大流行的广泛社会心理背景的影响。尽管这项研究存在局限性,如主要关注 BNT162b2 疫苗和观察性研究设计,但它提供了系统的多疫苗分析,填补了现有文献的一个重要空白。本综述强调了持续监测精神科 AEs 的必要性,并为未来的研究提供了指导,以调查潜在机制、确定风险因素并为临床管理提供信息。
{"title":"Psychiatric adverse events associated with the COVID-19 vaccines approved in the Republic of Korea: a systematic review.","authors":"Seungeun Ryoo, Miyoung Choi, Nam-Kyong Choi, Hyoung-Shik Shin, Jun Hee Woo, Byung-Joo Park, Sanghoon Oh","doi":"10.24171/j.phrp.2023.0325","DOIUrl":"10.24171/j.phrp.2023.0325","url":null,"abstract":"<p><p>This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023. Risk of bias was assessed using the Risk of Bias Assessment Tool for Non-randomized Studies 2.0. The study protocol was registered in the International Prospective Register of Systematic Reviews (CRD42023449422). Of the 301 articles initially selected, 7 were included in the final analysis. All studies reported on sleep disturbances, and 2 highlighted anxiety-related AEs. Sleep disorders like insomnia and narcolepsy were the most prevalent AEs, while depression was not reported. Our review suggests that these AEs may have been influenced by biological mechanisms as well as the broader psychosocial context of the COVID-19 pandemic. Although this study had limitations, such as a primary focus on the BNT162b2 vaccine and an observational study design, it offered a systematic, multi-vaccine analysis that fills a critical gap in the existing literature. This review underscores the need for continued surveillance of psychiatric AEs and guides future research to investigate underlying mechanisms, identify risk factors, and inform clinical management.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"107-114"},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140865957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishment of a registry of clinical data and bioresources for rare nervous system diseases. 建立罕见神经系统疾病临床数据和生物资源登记册。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-01 Epub Date: 2024-04-30 DOI: 10.24171/j.phrp.2023.0353
Dayoung Kim, Sooyoung Kim, Jin Myoung Seok, Kyong Jin Shin, Eungseok Oh, Mi Young Jeon, Joungkyu Park, Hee Jin Chang, Jinyoung Youn, Jeeyoung Oh, Eunhee Sohn, Jinse Park, Jin Whan Cho, Byoung Joon Kim

Rare diseases are predominantly genetic or inherited, and patients with these conditions frequently exhibit neurological symptoms. Diagnosing and treating many rare diseases is a complex challenge, and their low prevalence complicates the performance of research, which in turn hinders the advancement of therapeutic options. One strategy to address this issue is the creation of national or international registries for rare diseases, which can help researchers monitor and investigate their natural progression. In the Republic of Korea, we established a registry across 5 centers that focuses on 3 rare diseases, all of which are characterized by gait disturbances resulting from motor system dysfunction. The registry will collect clinical information and human bioresources from patients with amyotrophic lateral sclerosis, spinocerebellar ataxia, and hereditary spastic paraplegia. These resources will be stored at ICreaT and the National Biobank of Korea. Once the registry is complete, the data will be made publicly available for further research. Through this registry, our research team is dedicated to identifying genetic variants that are specific to Korean patients, uncovering biomarkers that show a strong correlation with clinical symptoms, and leveraging this information for early diagnosis and the development of treatments.

罕见病主要是遗传性疾病,这些疾病的患者经常表现出神经系统症状。诊断和治疗许多罕见病是一项复杂的挑战,而罕见病的低患病率又使研究工作复杂化,这反过来又阻碍了治疗方案的发展。解决这一问题的策略之一是建立国家或国际罕见病登记册,这有助于研究人员监测和调查罕见病的自然进展。在大韩民国,我们在 5 个中心建立了一个登记处,重点关注 3 种罕见疾病,所有这些疾病都以运动系统功能障碍导致的步态障碍为特征。登记处将收集肌萎缩侧索硬化症、脊髓小脑共济失调症和遗传性痉挛性截瘫患者的临床信息和人体生物资源。这些资源将储存在 ICreaT 和韩国国家生物库中。登记完成后,这些数据将公开供进一步研究使用。通过该登记处,我们的研究团队致力于确定韩国患者特有的基因变异,发现与临床症状密切相关的生物标志物,并利用这些信息进行早期诊断和开发治疗方法。
{"title":"Establishment of a registry of clinical data and bioresources for rare nervous system diseases.","authors":"Dayoung Kim, Sooyoung Kim, Jin Myoung Seok, Kyong Jin Shin, Eungseok Oh, Mi Young Jeon, Joungkyu Park, Hee Jin Chang, Jinyoung Youn, Jeeyoung Oh, Eunhee Sohn, Jinse Park, Jin Whan Cho, Byoung Joon Kim","doi":"10.24171/j.phrp.2023.0353","DOIUrl":"10.24171/j.phrp.2023.0353","url":null,"abstract":"<p><p>Rare diseases are predominantly genetic or inherited, and patients with these conditions frequently exhibit neurological symptoms. Diagnosing and treating many rare diseases is a complex challenge, and their low prevalence complicates the performance of research, which in turn hinders the advancement of therapeutic options. One strategy to address this issue is the creation of national or international registries for rare diseases, which can help researchers monitor and investigate their natural progression. In the Republic of Korea, we established a registry across 5 centers that focuses on 3 rare diseases, all of which are characterized by gait disturbances resulting from motor system dysfunction. The registry will collect clinical information and human bioresources from patients with amyotrophic lateral sclerosis, spinocerebellar ataxia, and hereditary spastic paraplegia. These resources will be stored at ICreaT and the National Biobank of Korea. Once the registry is complete, the data will be made publicly available for further research. Through this registry, our research team is dedicated to identifying genetic variants that are specific to Korean patients, uncovering biomarkers that show a strong correlation with clinical symptoms, and leveraging this information for early diagnosis and the development of treatments.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 2","pages":"174-181"},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082444/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peacetime preparedness for the vaccine adverse event. 和平时期应对疫苗不良事件的准备工作。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-01 Epub Date: 2024-04-30 DOI: 10.24171/j.phrp.2024.0113
Jong-Koo Lee
{"title":"Peacetime preparedness for the vaccine adverse event.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2024.0113","DOIUrl":"10.24171/j.phrp.2024.0113","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"15 2","pages":"95-96"},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082443/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140899873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges in capacity building of national immunization programs and emergency or pandemic vaccination responses in the Global Health Security Agenda member countries. 全球健康安全议程成员国在国家免疫计划能力建设和紧急或大流行疫苗接种应对方面面临的挑战。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-01 Epub Date: 2024-03-28 DOI: 10.24171/j.phrp.2023.0159
Sookhyun Lee, Jung Ju Oh, Sang Hyun Park, Dasol Ro, Ye Jin Jeong, So Yoon Kim
{"title":"Challenges in capacity building of national immunization programs and emergency or pandemic vaccination responses in the Global Health Security Agenda member countries.","authors":"Sookhyun Lee, Jung Ju Oh, Sang Hyun Park, Dasol Ro, Ye Jin Jeong, So Yoon Kim","doi":"10.24171/j.phrp.2023.0159","DOIUrl":"10.24171/j.phrp.2023.0159","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"182-185"},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140866774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-powered COVID-19 forecasting: a comprehensive comparison of advanced deep learning methods. 人工智能驱动的 COVID-19 预测:高级深度学习方法的综合比较。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2024-04-01 Epub Date: 2024-03-28 DOI: 10.24171/j.phrp.2023.0287
Muhammad Usman Tariq, Shuhaida Binti Ismail

Background: The coronavirus disease 2019 (COVID-19) pandemic continues to pose significant challenges to the public health sector, including that of the United Arab Emirates (UAE). The objective of this study was to assess the efficiency and accuracy of various deep-learning models in forecasting COVID-19 cases within the UAE, thereby aiding the nation's public health authorities in informed decision-making.

Methods: This study utilized a comprehensive dataset encompassing confirmed COVID-19 cases, demographic statistics, and socioeconomic indicators. Several advanced deep learning models, including long short-term memory (LSTM), bidirectional LSTM, convolutional neural network (CNN), CNN-LSTM, multilayer perceptron, and recurrent neural network (RNN) models, were trained and evaluated. Bayesian optimization was also implemented to fine-tune these models.

Results: The evaluation framework revealed that each model exhibited different levels of predictive accuracy and precision. Specifically, the RNN model outperformed the other architectures even without optimization. Comprehensive predictive and perspective analytics were conducted to scrutinize the COVID-19 dataset.

Conclusion: This study transcends academic boundaries by offering critical insights that enable public health authorities in the UAE to deploy targeted data-driven interventions. The RNN model, which was identified as the most reliable and accurate for this specific context, can significantly influence public health decisions. Moreover, the broader implications of this research validate the capability of deep learning techniques in handling complex datasets, thus offering the transformative potential for predictive accuracy in the public health and healthcare sectors.

目标:冠状病毒病 2019(COVID-19)大流行继续对包括阿拉伯联合酋长国(UAE)在内的公共卫生部门构成重大挑战。本研究旨在评估各种深度学习模型在预测阿联酋 COVID-19 病例方面的效率和准确性,从而帮助该国公共卫生部门做出知情决策:本研究利用了一个综合数据集,其中包括 COVID-19 确诊病例、人口统计数据和社会经济指标。训练和评估了多个先进的深度学习模型,包括长短期记忆(LSTM)、双向 LSTM、卷积神经网络(CNN)、CNN-LSTM、多层感知器和递归神经网络(RNN)模型。此外,还采用了贝叶斯优化方法对这些模型进行微调:评估框架显示,每个模型都表现出不同程度的预测准确性和精确性。具体而言,即使不进行优化,RNN 模型的表现也优于其他架构。对 COVID-19 数据集进行了全面的预测和透视分析:本研究超越了学术界限,提供了重要的见解,使阿联酋的公共卫生部门能够部署有针对性的数据驱动干预措施。RNN 模型被认为是在这一特定情况下最可靠、最准确的模型,可对公共卫生决策产生重大影响。此外,这项研究的广泛意义还验证了深度学习技术处理复杂数据集的能力,从而为公共卫生和医疗保健领域的预测准确性提供了变革潜力。
{"title":"AI-powered COVID-19 forecasting: a comprehensive comparison of advanced deep learning methods.","authors":"Muhammad Usman Tariq, Shuhaida Binti Ismail","doi":"10.24171/j.phrp.2023.0287","DOIUrl":"10.24171/j.phrp.2023.0287","url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic continues to pose significant challenges to the public health sector, including that of the United Arab Emirates (UAE). The objective of this study was to assess the efficiency and accuracy of various deep-learning models in forecasting COVID-19 cases within the UAE, thereby aiding the nation's public health authorities in informed decision-making.</p><p><strong>Methods: </strong>This study utilized a comprehensive dataset encompassing confirmed COVID-19 cases, demographic statistics, and socioeconomic indicators. Several advanced deep learning models, including long short-term memory (LSTM), bidirectional LSTM, convolutional neural network (CNN), CNN-LSTM, multilayer perceptron, and recurrent neural network (RNN) models, were trained and evaluated. Bayesian optimization was also implemented to fine-tune these models.</p><p><strong>Results: </strong>The evaluation framework revealed that each model exhibited different levels of predictive accuracy and precision. Specifically, the RNN model outperformed the other architectures even without optimization. Comprehensive predictive and perspective analytics were conducted to scrutinize the COVID-19 dataset.</p><p><strong>Conclusion: </strong>This study transcends academic boundaries by offering critical insights that enable public health authorities in the UAE to deploy targeted data-driven interventions. The RNN model, which was identified as the most reliable and accurate for this specific context, can significantly influence public health decisions. Moreover, the broader implications of this research validate the capability of deep learning techniques in handling complex datasets, thus offering the transformative potential for predictive accuracy in the public health and healthcare sectors.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":" ","pages":"115-136"},"PeriodicalIF":4.3,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11082441/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osong Public Health and Research Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1